Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread.

Clements AC, Magalhães RJ, Tatem AJ, Paterson DL, Riley TV.

Lancet Infect Dis. 2010 Jun;10(6):395-404. doi: 10.1016/S1473-3099(10)70080-3. Review.

PMID:
20510280
2.

[Clostridium-difficile-associated infections].

Eckert C, Barbut F.

Med Sci (Paris). 2010 Feb;26(2):153-8. doi: 10.1051/medsci/2010262153. Review. French.

3.

Emergence of Clostridium difficile-associated disease in North America and Europe.

Kuijper EJ, Coignard B, Tüll P; ESCMID Study Group for Clostridium difficile; EU Member States; European Centre for Disease Prevention and Control.

Clin Microbiol Infect. 2006 Oct;12 Suppl 6:2-18. Review.

4.

Clostridium difficile: a problem of concern in developed countries and still a mystery in Latin America.

Balassiano IT, Yates EA, Domingues RM, Ferreira EO.

J Med Microbiol. 2012 Feb;61(Pt 2):169-79. doi: 10.1099/jmm.0.037077-0. Epub 2011 Nov 24. Review.

PMID:
22116982
5.

[Dramatic increase of Clostridium difficile-associated diarrhea in Germany: has the new strain PCR-ribotype 027 already reached us?].

Reichardt C, Chaberny IF, Kola A, Mattner F, Vonberg RP, Gastmeier P.

Dtsch Med Wochenschr. 2007 Feb 2;132(5):223-8. Review. German. No abstract available.

PMID:
17252365
6.

[Epidemic risk of disease associated with a new strain of Clostridium difficile].

Arteaga A, Santa-Olalla P, Sierra MJ, Limia A, Cortés M, Amela C.

Enferm Infecc Microbiol Clin. 2009 May;27(5):278-84. doi: 10.1016/j.eimc.2008.01.003. Epub 2009 Apr 21. Review. Spanish.

PMID:
19386385
7.

New trends in Clostridium difficile virulence and pathogenesis.

Denève C, Janoir C, Poilane I, Fantinato C, Collignon A.

Int J Antimicrob Agents. 2009 Mar;33 Suppl 1:S24-8. doi: 10.1016/S0924-8579(09)70012-3. Review.

PMID:
19303565
8.

The Clostridium difficile PCR ribotype 027 lineage: a pathogen on the move.

Valiente E, Cairns MD, Wren BW.

Clin Microbiol Infect. 2014 May;20(5):396-404. doi: 10.1111/1469-0691.12619. Epub 2014 Apr 28. Review.

9.

What is the role of antimicrobial resistance in the new epidemic of Clostridium difficile?

Coia JE.

Int J Antimicrob Agents. 2009 Mar;33 Suppl 1:S9-12. doi: 10.1016/S0924-8579(09)70009-3. Review.

PMID:
19303572
10.

Molecular methods for detecting and typing of Clostridium difficile.

Collins DA, Elliott B, Riley TV.

Pathology. 2015 Apr;47(3):211-8. doi: 10.1097/PAT.0000000000000238. Review.

PMID:
25719853
11.

Update on Clostridium difficile associated disease.

Cloud J, Kelly CP.

Curr Opin Gastroenterol. 2007 Jan;23(1):4-9. Review.

PMID:
17133077
12.

[Update on Clostridium difficile infections].

Blanckaert K, Coignard B, Grandbastien B, Astagneau P, Barbut F.

Rev Med Interne. 2008 Mar;29(3):209-14. Epub 2007 Oct 22. Review. French.

PMID:
18023937
13.

Molecular epidemiology of Clostridium difficile for clinical practice.

Tschudin-Sutter S.

Swiss Med Wkly. 2014 Sep 10;144:w13995. doi: 10.4414/smw.2014.13995. eCollection 2014. Review.

14.

The emergence of 'hypervirulence' in Clostridium difficile.

Cartman ST, Heap JT, Kuehne SA, Cockayne A, Minton NP.

Int J Med Microbiol. 2010 Aug;300(6):387-95. doi: 10.1016/j.ijmm.2010.04.008. Epub 2010 May 23. Review.

PMID:
20547099
15.

Clostridium difficile infection seasonality: patterns across hemispheres and continents - a systematic review.

Furuya-Kanamori L, McKenzie SJ, Yakob L, Clark J, Paterson DL, Riley TV, Clements AC.

PLoS One. 2015 Mar 16;10(3):e0120730. doi: 10.1371/journal.pone.0120730. eCollection 2015. Review.

Supplemental Content

Support Center